New stroke drug combo aims to boost recovery in Late-Treated patients

NCT ID NCT07347626

Not yet recruiting Disease control Sponsor: Xinqiao Hospital of Chongqing Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding the drug eptifibatide after standard clot-dissolving treatment can help people with acute ischemic stroke recover better. It includes 786 adults who arrive at the hospital 4.5 to 24 hours after stroke symptoms start. The goal is to see if this combination reduces disability and improves daily function.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE

Contacts and locations

Locations

Ganzhou People's Hospital

Ganzhou, Jiangxi, 341000, China
The Affiliated Hospital of Jinggangshan University

Ji’an, Jiangxi, 343000, China
The First Affiliated Hospital of Gannan Medical University

Ganzhou, Jiangxi, 341000, China
The First Affiliated Hospital of Hainan Medical University

Haikou, Hainan, 570100, China
The First Affiliated Hospital of Nanchang University

Nanchang, Jiangxi, 330006, China
Xinqiao Hospital and The Second Affiliated Hospital

Chongqing, Chongqing Municipality, 400000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.